Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial
Norman Beischer Medical Research Foundation, University of Melbourne, and NHMRC. Funders had no role in study conduct or manuscript preparation.
Authors
- Joanne Said (ORCID: https://orcid.org/0000-0001-6263-0030)
- Veshni Pillay-Fuentes Lorente (ORCID: https://orcid.org/0000-0001-5365-0320)
- Anna Middleton (ORCID: https://orcid.org/0000-0003-3103-8098)
- Stephen Tong
- Catherine Cluver (ORCID: https://orcid.org/0000-0002-0406-8964)
- Vanessa Louw (ORCID: https://orcid.org/0000-0001-6074-2362)
- Tracy Kellermann (ORCID: https://orcid.org/0000-0003-1542-4976)
- Tu'uhevaha J. Kaitu'u-Lino
- Fiona C. Brownfoot
- Eric Decloedt
- Zohra Bibi Abdulla
- Elif Kadife
Institutions
- Stellenbosch University (ZA)
- Mercy Hospital for Women (AU)
- Tygerberg Hospital (ZA)
- Sunshine Hospital (AU)
- Melbourne Health (AU)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.eclinm.2026.103779
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00